Henry Schein FY2024 EPS Forecast Lifted by Leerink Partnrs

Henry Schein, Inc. (NASDAQ:HSIC - Free Report) - Leerink Partnrs upped their FY2024 EPS estimates for Henry Schein in a research note issued on Monday, October 14th. Leerink Partnrs analyst M. Cherny now forecasts that the company will post earnings per share of $4.76 for the year, up from their previous estimate of $4.75. The consensus estimate for Henry Schein's current full-year earnings is $4.74 per share. Leerink Partnrs also issued estimates for Henry Schein's Q4 2024 earnings at $1.25 EPS, FY2025 earnings at $5.31 EPS, FY2026 earnings at $5.87 EPS and FY2027 earnings at $6.44 EPS.

Henry Schein (NASDAQ:HSIC - Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $1.23 EPS for the quarter, topping analysts' consensus estimates of $1.22 by $0.01. The company had revenue of $3.10 billion during the quarter, compared to the consensus estimate of $3.27 billion. Henry Schein had a return on equity of 13.19% and a net margin of 2.82%. The company's quarterly revenue was up .0% on a year-over-year basis. During the same quarter last year, the company earned $1.31 EPS.

Several other analysts have also weighed in on the stock. Piper Sandler reiterated an "overweight" rating and set a $86.00 target price on shares of Henry Schein in a research report on Friday, June 21st. Barrington Research reiterated an "outperform" rating and issued a $82.00 price objective on shares of Henry Schein in a research note on Friday, September 20th. Baird R W raised Henry Schein from a "hold" rating to a "strong-buy" rating in a report on Monday, July 22nd. UBS Group decreased their price target on Henry Schein from $75.00 to $72.00 and set a "neutral" rating on the stock in a research note on Wednesday, August 7th. Finally, Evercore ISI increased their price objective on Henry Schein from $70.00 to $74.00 and gave the stock an "in-line" rating in a research note on Tuesday, October 8th. One investment analyst has rated the stock with a sell rating, six have assigned a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $77.50.

Henry Schein Stock Performance

HSIC traded down $0.08 during trading on Thursday, reaching $71.67. 721,683 shares of the company's stock were exchanged, compared to its average volume of 1,338,305. The company has a market capitalization of $9.18 billion, a P/E ratio of 24.21, a PEG ratio of 1.98 and a beta of 0.86. The company has a quick ratio of 0.90, a current ratio of 1.55 and a debt-to-equity ratio of 0.46. The business has a 50 day moving average price of $70.26 and a 200 day moving average price of $69.90. Henry Schein has a fifty-two week low of $60.01 and a fifty-two week high of $82.63.

Insiders Place Their Bets

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the firm's stock in a transaction that occurred on Friday, September 6th. The shares were sold at an average price of $69.30, for a total value of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares of the company's stock, valued at $4,978,026.90. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 1.14% of the company's stock.

Hedge Funds Weigh In On Henry Schein

Hedge funds have recently added to or reduced their stakes in the company. Summit Securities Group LLC bought a new position in Henry Schein in the second quarter valued at approximately $31,000. Beach Investment Counsel Inc. PA bought a new position in shares of Henry Schein in the 2nd quarter worth $37,000. Blue Trust Inc. boosted its position in shares of Henry Schein by 104.2% in the 2nd quarter. Blue Trust Inc. now owns 931 shares of the company's stock worth $60,000 after purchasing an additional 475 shares during the last quarter. Mather Group LLC. grew its stake in shares of Henry Schein by 16.8% during the second quarter. Mather Group LLC. now owns 1,502 shares of the company's stock worth $96,000 after purchasing an additional 216 shares during the period. Finally, Livforsakringsbolaget Skandia Omsesidigt increased its holdings in Henry Schein by 282.1% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,490 shares of the company's stock valued at $109,000 after purchasing an additional 1,100 shares during the last quarter. Institutional investors own 96.62% of the company's stock.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.